UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June~~December 3031, 2017

Commission file number 33-37809-NY

~~CASTLE~~ENERKON ~~HOLDING~~SOLAR ~~CORP~~INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Its Charter)

Nevada		77-0121957
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. ~~EmployerIdentification~~Employer Identification No.)

111 West Sunrise Highway, Second Floor East

Freeport, NY 11520

(516)-378-1000

(Address of Principal Executive Offices, Zip Code & Telephone Number)

Securities registered pursuant to Section 12(b) of the Act:

None

Securities registered pursuant to section 15(d) of the Act:

Common Stock, $0.0025 par value

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes x No o

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes o No x

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (ss.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	¨	Smaller reporting company	x
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

As of ~~August~~January 426, ~~2017~~2018, the registrant had 47,003,510 shares of common stock issued and 46,414,710 shares of common stock outstanding, as well as 522,250 Class A Convertible preferred shares issued and outstanding and 100,000 Class B Preferred shares issued and outstanding.

~~Castle~~Enerkon ~~Holding~~Solar ~~Corp~~International, Inc.

TABLE OF CONTENTS

Quarterly Period Ended ~~June~~December 3031, 2017

		~~Page No.~~	Page No.
PART I – FINANCIAL INFORMATION
PART I – Financial Information
Item 1.	Financial Statements	3	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operaions	13	13
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	14	14
Item 4.	Controls and Procedures	14	14
PART II – OTHER INFORMATION
PART II – Other Information
Item 1.	Legal Proceedings	15	15
Item 1A.	Risk Factors	15	15
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	15	15
Item 3.	Defaults Upon Senior Securities	15	15
Item 4.	Mine Safety Disclosures	15	15
Item 5.	Other Information	15	15
Item 6.	Exhibits	15	16
		16
SIGNATURES			17
SIGNATURES		17

PART I

ITEM 1. FINANCIAL STATEMENTS

CASTLE HOLDING CORP. AND SUBSIDIARIES
ENERKON SOLAR INTERNATIONAL, INC. AND SUBSIDIARIES
Consolidated Statements of Financial Condition
(Unaudited and Unreviewed)
	June 30, 2017			September 30, 2016
	December 31, 2017			September 30, 2017
Assets
Cash and cash equivalents	$	~~109~~115,~~900~~965		$	41120,~~643~~640
Marketable securities, at market value		322,~~300~~100			~~140~~5,~~362~~100
Inventory		1216,~~536~~883			39,~~405~~027
Investment in Emergent Health Corporation common stock		4020,000			6020,000
License agreement with Emergent Health Corporation		30,000			30,000
Other assets		2			5,497
Other assets		2			2
Total assets	$	174,950		$	160,264
Total assets	$	195,738		$	275,412
Liabilities and Stockholders' Equity
Liabilities:
Margin liability to broker	$	-		$	19,751
Accounts payable and accrued expenses	$	3,438		$	4,288
Accounts payable and accrued expenses		3,427			785
Loans payable to affiliates		15,080			18,081
Loans payable to affiliates		18,081			18,081
Total liabilities		18,518			22,369
Total liabilities		21,508			38,617
Stockholders' equity:
Preferred stock, $.01 par value; authorized 8,900,000 and 8,900,000 shares, respectively; none issued and outstanding		-			-
Preferred stock, $.01 par value; authorized
Class A Convertible Preferred stock, $.01 par value; authorized 1,000,000 shares, issued and outstanding 522,250 and 522,250 shares, respectively		5,223			5,223
8,900,000 and 8,900,000 shares, respectively; none issued and outstanding		-			-
Class B Preferred stock, $.01 par value; authorized 100,000 shares, issued and outstanding 100,000 and 100,000 shares, respectively		1,000			1,000
Class A Convertible Preferred stock, $.01 par value;
Common stock, $.0025 par value; authorized 200,000,000 shares, issued 47,003,510 and 47,003,510 shares, respectively (net of 261,000 shares "stopped" and requested to be cancelled)		117,509			117,509
authorized 1,000,000 shares, issued and outstanding
Treasury common stock - 588,800 and 588,800 shares, respectively - at cost		(32,620	)		(32,620	)
522,250 and 522,250 shares, respectively		5,223			5,223
Class B Preferred stock, $.01 par value; authorized
100,000 shares, issued and outstanding 100,000
and 100,000 shares, respectively		1,000			1,000
Common stock, $.0025 par value; authorized
200,000,000 shares, issued 47,003,510 and
47,003,510 shares, respectively (net of 261,000 shares
"stopped" and requested to be cancelled)		117,509			117,509
Treasury common stock - 588,800 and 588,800 shares,
respectively - at cost		(32,620	)		(32,620	)
Additional paid-in capital		1,883,177			1,883,177
Accumulated deficit		(1,~~800~~817,~~059~~857	)		(1,~~737~~836,~~494~~394	)
Total stockholders' equity		~~174~~156,~~230~~432			~~236~~137,~~795~~895
Total liabilities and stockholders' equity	$	~~195~~174,~~738~~950		$	~~275~~160,~~412~~264

See notes to consolidated financial statements.

Table of Contents

CASTLE HOLDING CORP. AND SUBSIDIARIES
ENERKON SOLAR INTERNATIONAL, INC. AND SUBSIDIARIES
Consolidated Statements of Operations
(Unaudited and Unreviewed)
	Three Months Ended June 30,						Nine Months Ended June 30,
	Three Months Ended December 31,
	2017			2016			~~2017~~			~~2016~~
Sales	$	1722,~~317~~156		$	~~959~~-		$	~~36,762~~		$	~~8,212~~
Cost of sales		43,~~637~~431			~~211~~-			~~7,523~~			~~1,058~~
Gross profit		1218,~~680~~725			~~748~~-			~~29,239~~			~~7,154~~
Selling expenses		1110,~~414~~664			~~506~~1,105			~~19,805~~			~~3,843~~
General and administrative expenses		86,~~289~~524			154,~~572~~124			~~14,102~~			~~50,582~~
Total operating expenses		1917,~~703~~188			165,~~078~~229			~~33,907~~			~~54,425~~
Income (loss) from operations		(71,~~023~~537	)		(155,~~330~~229	)		~~(4,668~~	)		~~(47,271~~	)
Other income (expense):
Interest and dividends revenues		-			141,~~501~~600			~~1,601~~			~~21,751~~
Royalties revenues		-			-1,500			~~1,500~~			~~572~~
Net gain (loss) on marketable securities		~~(100~~17,000	)		(9039,~~585~~059	)		~~(40,473~~	)		~~(42,635~~	)
Impairment of investment in Emergent Health Corporation common stock		-			-			(20,000	)		(80,000	)
Interest expense		-			(446	)
Interest expense		(3	)		(87	)		(525	)		(87	)
Total other income (expense) - net		17,000			(36,405	)
Total other income (expense) - net		(103	)		(76,171	)		(57,897	)		(100,399	)
Income (loss) before income taxes		18,537			(41,634	)
Income (loss) before income taxes		(7,126	)		(91,501	)		(62,565	)		(147,670	)
Provision for income taxes		-			-
Provision for income taxes		-			-			-			-
Net income (loss)	$	18,537		$	(41,634	)
Net income (loss)	$	(7,126	)	$	(91,501	)	$	(62,565	)	$	(147,670	)
Net income (loss) per common share:
Net income (loss) per common share:
Basic	$	(0.00	)	$	(0.00	)
Basic	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Diluted	$	(0.00	)	$	(0.00	)
Diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Weighted average number of common shares outstanding:
Weighted average number of common shares outstanding:
Basic		46,414,710			46,414,710
Basic		46,414,710			46,407,237			46,414,710			45,065,562
Diluted		46,936,960			46,936,960
Diluted		46,936,960			46,929,487			46,936,960			45,587,812

See notes to consolidated financial statements.

Table of Contents

~~CASTLE~~ENERKON ~~HOLDING~~SOLAR ~~CORP~~INTERNATIONAL, INC. AND SUBSIDIARIES ~~Consolidated Statements of Changes in Stockholders' Equity For the Period October 1, 2015 to June 30, 2017 (Unaudited and Unreviewed)~~

	Class A Convertible Preferred Stock, $.01 Par Value				Class B Preferred Stock, $.01 Par Value				Common Stock, $.0025 Par Value				Treasury Common Stock, $.0025 Par Value						Additional Paid-in		Accumulated			Total Stock- holders'
	Shares		Amount		Shares		Amount		Shares		Amount		Shares			Amount			Capital		Deficit			Equity
Balances, September 30, 2015		522,250	$	5,223		100,000	$	1,000		44,983,510	$	112,459		(588,800	)	$	(32,620	)	$	1,833,527	$	(1,458,943	)	$	460,646
Issuance of common shares on April 1, 2016 for 1,500,000 free trading shares of Gold Mining USA Inc. ("GMUI") common stock		-		-		-		-		2,000,000		5,000		-			-			47,500		-			52,500
Issuance of common shares on May 5, 2016 for legal services rendered		-		-		-		-		20,000		50		-			-			2,500		-			2,200
Net loss		-		-		-		-		-		-		-			-			-		(278,551	)		(278,551	)
Balances, September 30, 2016		522,250		5,223		100,000		1,000		47,003,510		117,509		(588,800	)		(32,620	)		1,883,177		(1,737,494	)		236,795
Net loss for the nine months ended June 30, 2017		-		-		-		-		-		-		-			-			-		(62,565	)		(62,565	)
Balances, June 30, 2017		522,250	$	5,223		100,000	$	1,000		47,003,510	$	117,509		(588,800	)	$	(32,620	)	$	1,883,177	$	(1,800,059	)	$	174,230

Consolidated Statements of Changes in Stockholders' Equity

~~See~~For ~~notes~~the Period October 1, 2016 to ~~consolidated~~December ~~financial~~31, ~~statements.~~2017

5(Unaudited ~~Table~~and ~~of Contents~~Unreviewed)

CASTLE HOLDING CORP. AND SUBSIDIARIES
	Class A Convertible Preferred Stock, $.01 Par Value						Class B Preferred Stock, $.01 Par Value				Common Stock, $.0025 Par Value				Treasury Common Stock, $.0025 Par Value						Additional Paid-in		Accumulated			Total Stock- holders'
Consolidated Statements of Cash Flows
	Shares			Amount			Shares		Amount		Shares		Amount		Shares			Amount			Capital		Deficit			Equity
(Unaudited and Unreviewed)
Balances, September 30, 2016		522,250		$	5,223			100,000	$	1,000		47,003,510	$	117,509		(588,800	)	$	(32,620	)	$	1,883,177	$	(1,737,494	)	$	236,795
	Nine Months Ended June 30,
Net loss for the year ended September 30, 2017		-			-			-		-		-		-		-			-			-		(98,900	)		(98,900	)
	2017			2016
Balances, September 30, 2017		522,250			5,223			100,000		1,000		47,003,510		117,509		(588,800	)		(32,620	)		1,883,177		(1,836,394	)		137,895
Cash flows from operating activities:
Net income for the three months ended December 31, 2017		-			-			-		-		-		-		-			-			-		18,537			18,537
Net income (loss)	$	(62,565	)	$	(147,670	)
Balances, December 31, 2017		522,250		$	5,223			100,000	$	1,000		47,003,510	$	117,509		(588,800	)	$	(32,620	)	$	1,883,177	$	(1,817,857	)	$	156,432
Adjustments to reconcile net income (loss) to net
cash provided by (used in) operating activities:
Issuance of common stock for legal services		-			2,200
Impairment of investment in Emergent Health Corporation common stock		20,000			80,000
Changes in operating assets and liabilities:
Marketable securities		137,062			43,327
Inventory		(9,131	)		(483	)
Margin liability to broker		(19,751	)		-
Accounts payable and accrued expenses		2,642			(481	)
Net cash provided by (used in) operating activities		68,257			(23,107	)
Cash flows from investing activities		-			-
Cash flows from financing activities		-			-
Net increase (decrease) in cash and cash equivalents		68,257			(23,107	)
Cash and cash equivalents, beginning of period		41,643			65,969
Cash and cash equivalents, end of period	$	109,900		$	42,862
Supplemental disclosures of cash flow information:
Interest paid	$	525		$	82
Income taxes paid	$	-		$	-
Non-cash investing and financing activities:
Issuance of 2,000,000 restricted shares of CHOD common stock in exchange for 1,500,000 free trading shares of Gold Mining USA Inc., (“GMUI”) common stock	$	-		$	52,500

See notes to consolidated financial statements.

65 Table of Contents

~~CASTLE~~ENERKON ~~HOLDING~~SOLAR ~~CORP~~INTERNATIONAL, INC. AND SUBSIDIARIES

~~Notes~~Consolidated toStatements ~~Consolidated~~of ~~Financial~~Cash ~~Statements~~Flows

~~Three~~(Unaudited and ~~Nine Months Ended June 30, 2017 and 2016~~Unreviewed)

(Unaudited and Unreviewed)

	Three Months Ended December 31,
	2017			2016
Cash flows from operating activities:
Net income (loss)	$	18,537		$	(41,634	)
Adjustments to reconcile net income (loss) to net
cash provided by (used in) operating activities		-			-
Changes in operating assets and liabilities:
Marketable securities		(17,000	)		38,162
Inventory		(7,856	)		-
Other assets		5,495			(5,162	)
Margin liability to broker		-			(256	)
Accounts payable and accrued expenses		(850	)		140
Deferred revenue		-			3,211

Net cash provided by (used in) operating activities		(1,674	)		(5,539	)

Cash flows from investing activities		-			-

Cash flows from financing activities:
Repayment of loans payable to affiliates		(3,001	)		-
Net cash provided by (used in) financing activities		(3,001	)		-

Net increase (decrease) in cash and cash equivalents		(4,675	)		(5,539	)
Cash and cash equivalents, beginning of period		120,640			41,643

Cash and cash equivalents, end of period	$	115,965		$	36,104

Supplemental disclosures of cash flow information:
Interest paid	$	-		$	446
Income taxes paid	$	-		$	-

1.See ~~ORGANIZATION~~notes to consolidated financial statements.

~~Castle~~6 ~~Holding~~Table ~~Corp. (“CHOD”) is a holding company which was incorporated in Nevada on June 13, 1986. The subsidiaries~~ of ~~CHOD are as follows:~~Contents

1.ENERKON ~~Castle~~SOLAR ~~Royalties Corp. (incorporated in New York April 11~~INTERNATIONAL, ~~1991) – name changed from Church Street Securities Corp~~INC. onAND March 16, 2015; assignee of License Agreement with Emergent Health Corporation effective March 16, 2015 (see Note 5). 2. SAS Health and Beauty Corp. (incorporated in New York May 27, 1994) – name changed from Wall Street Indians, Ltd. on March 31, 2015; manufactures and markets a skin care product (commencing July 2015) and vitamin supplements (commencing November 2016). 3. The Unlisted Stock Market Corporation (incorporated in New York December 9, 1999) – no operations from inception. 4. Shark Venture Capital Inc. (incorporated in Nevada December 22, 2014) – plans to engage in venture capital activities.SUBSIDIARIES

2.Notes ~~SUMMARY~~to OFConsolidated ~~SIGNIFICANT~~Financial ~~ACCOUNTING POLICIES~~Statements

~~Interim~~Three ~~financial~~Months ~~statements~~Ended –December The accompanying unaudited interim financial statements have been prepared by management in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly31, ~~they~~2017 ~~do not include all information~~ and footnotes required by generally accepted accounting principles for annual audited financial statements. In the opinion of management, the unaudited financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments considered necessary for a fair presentation. 2016

~~The~~(Unaudited ~~results of operations for the three~~ and nine months ended June 30, 2017 are not necessarily indicative of the results to be expected for the year ending September 30, 2017. The accompanying unaudited interim financial statements should be read in conjunction with the Company’s financial statements and notes related thereto for the years ended September 30, 2016 and 2015 included in our Form 10-K filed with the SEC. Unreviewed)

1. ORGANIZATION

~~Principles~~Enerkon ofSolar ~~consolidation~~International, –Inc. ~~The~~(“ENKS”) ~~consolidated~~is ~~financial~~a ~~statements~~holding ~~include~~company ~~the~~which ~~accounts~~was ofincorporated ~~CHOD~~in ~~and~~Nevada ~~its~~on ~~subsidiaries~~June ~~(collectively~~13, 1986. The name of the “Company was changed from Castle Holding Corp. (“CHOD”). ~~All~~to ~~significant~~ENKS ~~intercompany~~on ~~balances~~November ~~and~~2, ~~transactions~~2017. ~~have~~The ~~been~~subsidiaries ~~eliminated~~of inENKS ~~consolidation.~~are as follows:

~~Use~~1. ofCastle ~~estimates~~Royalties Corp. (incorporated in New York April 11, 1991) – ~~The~~name ~~preparation~~changed offrom ~~the~~Church ~~financial~~Street ~~statements~~Securities inCorp. ~~conformity~~on March 16, 2015; assignee of License Agreement with ~~accounting~~Emergent ~~principles~~Health ~~generally~~Corporation ~~accepted~~effective inMarch ~~the~~16, ~~United~~2015 ~~States~~(see ~~requires~~Note ~~management~~5). to2. ~~make~~SAS ~~estimates~~Health and ~~assumptions~~Beauty ~~that~~Corp. ~~affect~~(incorporated ~~the~~in ~~amounts~~New ~~reported~~York inMay ~~the~~27, ~~financial~~1994) ~~statements~~– name changed from Wall Street Indians, Ltd. on March 31, 2015; manufactures and ~~accompanying~~markets ~~notes~~a skin care product (commencing July 2015) and vitamin supplements (commencing November 2016). ~~Actual~~3. ~~results~~The ~~could~~Unlisted ~~differ~~Stock Market Corporation (incorporated in New York December 9, 1999) – no operations from ~~those~~inception. ~~estimates~~4. Shark Venture Capital Inc. (incorporated in Nevada December 22, 2014) – plans to engage in venture capital activities.

~~Cash~~2. ~~and~~SUMMARY ~~cash~~OF ~~equivalents~~SIGNIFICANT ‑ACCOUNTING ~~The Company considers highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.~~POLICIES

~~Marketable~~Interim ~~securities~~financial ‑statements ~~Marketable~~– ~~securities~~The ~~consist~~accompanying ofunaudited ~~trading~~interim ~~securities~~financial ~~valued~~statements athave ~~market.~~been ~~All~~prepared ~~fair~~by ~~value~~management ~~measurements~~in ~~are~~accordance ~~based~~with onaccounting ~~Level~~principles 1generally ~~inputs~~accepted ~~(i.e.,~~in ~~closing~~the ~~trading~~United ~~prices~~States of ~~respective~~America ~~marketable~~for ~~securities).~~interim ~~Unrealized~~financial ~~gains~~information and ~~losses~~pursuant ~~are~~to ~~reflected~~rules inand ~~income~~regulations ~~($310,529~~of the Securities and Exchange Commission (~~$43,231~~“SEC”). Accordingly, they do not include all information and footnotes required by generally accepted accounting principles for ~~the~~annual ~~nine~~audited ~~months~~financial ~~ended~~statements. ~~June~~In 30the opinion of management, ~~2017~~the unaudited financial statements have been prepared on the same basis as the annual financial statements and ~~2016,~~reflect ~~respectively)~~all adjustments considered necessary for a fair presentation.

7The ~~Table~~results of ~~Contents~~operations for the three months ended December 31, 2017 are not necessarily indicative of the results to be expected for the year ending September 30, 2018. The accompanying unaudited interim financial statements should be read in conjunction with the Company’s financial statements and notes related thereto for the years ended September 30, 2017 and 2016 included in our Form 10-K filed with the SEC.

~~CASTLE~~Principles ~~HOLDING~~of ~~CORP~~consolidation – The consolidated financial statements include the accounts of ENKS and its subsidiaries (collectively, the “Company”). ~~AND~~All ~~SUBSIDIARIES~~significant intercompany balances and transactions have been eliminated in consolidation.

~~Notes~~Use of estimates – The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to ~~Consolidated~~make ~~Financial~~estimates ~~Statements~~and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

~~Three~~Cash and ~~Nine~~cash ~~Months~~equivalents ~~Ended~~- ~~June~~The ~~30,~~Company ~~2017~~considers ~~and~~highly ~~2016~~liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.

~~(Unaudited~~7 ~~and~~Table ~~Unreviewed)~~of Contents

~~Inventory~~ENERKON –SOLAR ~~Inventory is stated at the lower of cost (first–in~~INTERNATIONAL, ~~first–out method) or market (net realizable value)~~INC. AtAND ~~June 30, 2017 and September 30, 2016, substantially all inventory are finished goods available for sale.~~ SUBSIDIARIES

~~Revenue~~Notes ~~recognition – Revenues are recognized upon delivery of the products, at which time title passes~~ to ~~the~~Consolidated ~~customer,~~Financial ~~provided that: there are no uncertainties regarding customer acceptance; persuasive evidence of an arrangement exists; the sales price is fixed or determinable; and collectibility is deemed probable.~~Statements

~~Income~~Three ~~taxes~~Months –Ended ~~Income~~December ~~taxes~~31, ~~are~~2017 ~~accounted for under the assets~~ and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled.2016

~~Net income~~ (~~loss)~~Unaudited per common share – Basic net income (loss) per common share is calculated based upon the weighted average number of common shares outstanding. Diluted net income (loss) per common share is calculated based upon the weighted average number of common shares outstanding and ~~dilutive convertible preferred shares outstanding.~~Unreviewed)

Marketable securities - Marketable securities consist of trading securities valued at market. All fair value measurements are based on Level 1 inputs (i.e., closing trading prices of respective marketable securities). Unrealized gains and losses are reflected in income ($17,000 and ($38,162) for the three months ended December 31, 2017 and 2016, respectively).

~~Recent~~Inventory ~~accounting pronouncements~~ – ~~Certain~~Inventory ~~accounting~~is ~~pronouncements~~stated ~~have~~at ~~been issued by~~ the ~~FASB~~lower ~~and~~of ~~other~~cost ~~standard~~(first–in, ~~setting~~first–out ~~organizations~~method) ~~which~~or ~~are~~market ~~not~~(net ~~yet~~realizable ~~effective and therefore have not yet been adopted by the Company~~value). ~~The~~At ~~impact~~December on31, ~~the~~2017 ~~Company’s financial position~~ and ~~results~~September of30, ~~operations~~2017, ~~from~~substantially ~~adoption~~all ofinventory ~~these~~are ~~standards~~finished isgoods ~~not~~available ~~expected~~for ~~to be material~~sale.

3.Revenue ~~MARKETABLE~~recognition ~~SECURITIES~~– Revenues are recognized upon delivery of the products, ATat ~~MARKET~~which ~~VALUE~~time title passes to the customer, provided that: there are no uncertainties regarding customer acceptance; persuasive evidence of an arrangement exists; the sales price is fixed or determinable; and collectibility is deemed probable.

AtIncome ~~June~~taxes ~~30,~~– ~~2017~~Income taxes are accounted for under the assets and ~~September~~liability ~~30,~~method. ~~2016,~~Deferred ~~marketable~~tax ~~securities~~assets ~~consist~~and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of: existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled.

	June 30, 2017		September 30, 2016
32,000 shares, Medallion Financial Group (MFIN)	$	-	$	135,040
1,000,000 and 1,400,000 shares, respectively, Gold Mining USA Inc. (GMUI)		3,200		5,222
Various		100		100
Total	$	3,300	$	140,362

Net income (loss) per common share – Basic net income (loss) per common share is calculated based upon the weighted average number of common shares outstanding. Diluted net income (loss) per common share is calculated based upon the weighted average number of common shares outstanding and dilutive convertible preferred shares outstanding.

8Recent ~~Table~~accounting pronouncements – Certain accounting pronouncements have been issued by the FASB and other standard setting organizations which are not yet effective and therefore have not yet been adopted by the Company. The impact on the Company’s financial position and results of ~~Contents~~operations from adoption of these standards is not expected to be material.

~~CASTLE~~3. ~~HOLDING~~MARKETABLE ~~CORP.~~SECURITIES, ~~AND~~AT ~~SUBSIDIARIES~~MARKET VALUE

~~Notes~~At toDecember ~~Consolidated~~31, ~~Financial~~2017 ~~Statements~~and September 30, 2017, marketable securities consist of:

Three and Nine Months Ended June 30, 2017 and 2016

	December 31, 2017		September 30, 2017

1,000,000 and 1,000,000 shares, respectively, Gold Mining USA Inc. (GMUI)	$	22,000	$	5,000
Various		100		100

Total	$	22,100	$	5,100

~~(Unaudited~~8 ~~and~~Table ~~Unreviewed)~~of Contents

4.ENERKON ~~INVESTMENT~~SOLAR ININTERNATIONAL, ~~EMERGENT~~INC. ~~HEALTH~~AND ~~CORPORATION COMMON STOCK~~SUBSIDIARIES

OnNotes ~~November 20. 2014, pursuant~~ to aConsolidated ~~Stock~~Financial Purchase Agreement involving a change in control of CHOD, CHOD acquired 2,000,000 restricted shares of Emergent Health Corporation (“EMGE”) common stock in exchange for the issuance of 2,000,000 restricted shares of CHOD common stock. The EMGE investment was initially valued at an estimated fair value of $250,000. The closing trading price of EMGE free trading common stock at November 20, 2014 was $0.49 per share.Statements

AtThree ~~September~~Months ~~30,~~Ended ~~2015, the Company recognized an impairment loss on the investment in EMGE common stock of $90,000 and reduced the carrying value from $250,000 to $160,000. At~~ December 31, 2015, the Company recognized an additional impairment loss on the investment in EMGE common stock of $40,000 and reduced the carrying value from $160,000 to $120,000. At March 31, 2016, the Company recognized an additional impairment loss on the investment in EMGE common stock of $40,000 and reduced the carrying value from $120,000 to $80,000. At September 30, 2016, the Company recognized an additional impairment loss on the investment in EMGE common stock of $20,000 and reduced the carrying value from $80,000 to $60,000. At March 31, 2017, ~~the Company recognized an additional impairment loss on the investment in EMGE common stock of $20,000~~ and ~~reduced the carrying value from $60,000 to $40,000. The closing trading price of EMGE free trading common stock at September 30,~~ 2016 ~~and June 30, 2017 was $0.0326 per share and $0.0332 per share, respectively.~~

5.(Unaudited ~~LICENSE~~and ~~AGREEMENT WITH EMERGENT HEALTH CORPORATION~~Unreviewed)

4. INVESTMENT IN EMERGENT HEALTH CORPORATION COMMON STOCK

On November 20,. 2014, pursuant to ~~the~~a Stock Purchase Agreement involving a change in control of ~~CHOD~~ENKS, ~~CHOD~~ENKS ~~was~~acquired ~~assigned effective January 1~~2, ~~2015 the License Agreement between Cappello’s~~000,000 ~~Inc,~~restricted ~~(Licensor)~~shares ~~and~~of ~~EMGE~~Emergent ~~(Licensee)~~Health ~~dated~~Corporation ~~August 26, 2014~~ (~~the~~ “EMGE ~~License Agreement~~”) common stock in exchange for the issuance of 2,000,000 restricted shares of ~~CHC~~ENKS common stock. The EMGE ~~License~~investment ~~Agreement~~ was initially valued at ~~its~~an estimated fair value of $30250,000. ~~based~~The ~~upon~~closing trading price of EMGE free trading common stock at November 20, 2014 ~~royalties~~was $0.49 per share.

~~The~~At ~~EMGE~~September ~~License~~30, ~~Agreement~~2015, ~~provided~~the ~~for~~Company ~~Licensee’s~~recognized ~~payment~~an ofimpairment ~~quarterly~~loss ~~royalty~~on ~~payments~~the toinvestment ~~Licensor~~in ~~equal~~EMGE tocommon 5%stock of $90,000 and reduced the ~~first~~carrying value from $1250,000 to $160,000. ofAt ~~annual~~December ~~net~~31, ~~sales~~2015, of the ~~Licensed~~Company ~~Products,~~recognized 4%an ofadditional ~~the~~impairment ~~next~~loss ~~$1,000,000~~on ofthe ~~annual~~investment ~~net~~in ~~sales,~~EMGE 3%common stock of ~~the next~~ $140,000~~,000~~ ofand ~~annual~~reduced ~~net~~the ~~sales,~~carrying 2%value offrom ~~the~~$160,000 ~~next~~to $2120,000~~,000~~. ofAt ~~annual~~March ~~net~~31, ~~sales~~2016, ~~and~~the 1%Company ofrecognized ~~all~~an additional ~~annual~~impairment ~~net~~loss ~~sales.~~on ~~The~~the ~~term~~investment ofin ~~the~~ EMGE ~~License~~common ~~Agreement~~stock ~~was~~of to$40,000 ~~expire~~and ~~upon~~reduced the ~~expiration~~carrying ofvalue ~~the~~from ~~last~~$120,000 to ~~expire~~$80,000. ofAt ~~the~~September ~~Patent~~30, ~~Rights.~~2016, In the ~~event~~Company ~~the~~recognized ~~Base~~an ~~Sales~~additional ofimpairment ~~any~~loss ~~one~~on orthe ~~more~~investment ofin ~~the~~EMGE ~~Licensed~~common ~~Products~~stock ~~did~~of ~~not~~$20,000 ~~increase~~and byreduced ~~15%~~the ~~per~~carrying ~~year~~value ~~over~~from ~~each~~$80,000 ~~prior~~to ~~calendar~~$60,000. ~~year~~At ~~(“Underperforming~~March ~~Licensed~~31, ~~Products”)~~2017, ~~and~~ the ~~Licensee~~Company ~~did~~recognized ~~not~~an ~~pay~~additional ~~royalties~~impairment ~~based~~loss on ~~15%~~the ~~annual~~investment ~~increases~~ in ~~Base~~EMGE ~~Sales~~common ~~for~~stock ~~the~~of ~~Underperforming Licensed Product(s)~~$20,000 ~~Licensor~~and ~~could~~reduced ~~terminate~~ the ~~license~~carrying ~~for~~value ~~such Underperforming Licensed Product(s) or convert the license~~ from an$60,000 ~~exclusive license~~ to ~~a non-exclusive license for such Underperforming Licensed Product(s)~~$40,000. ~~During~~At ~~the~~September ~~term~~30, ~~Licensor~~2017, ~~was~~the toCompany ~~keep~~recognized ~~Licensee~~an ~~informed~~additional ofimpairment ~~the~~loss ~~progress~~on of the ~~Patent~~investment ~~Rights~~ in ~~the~~EMGE ~~U.S.~~common ~~Patent~~stock ~~Office~~of ~~and~~$20,000 ~~was to direct~~ and ~~control~~reduced ~~all aspects of~~ the ~~prosecution~~carrying ~~and~~value ~~maintenance~~from of$40,000 ~~the~~to ~~Patent~~$20,000. ~~Rights~~The ~~using~~closing ~~patent~~trading ~~counsel~~price of ~~its~~EMGE ~~choice;~~free ~~Licensee~~trading ~~was~~common tostock ~~pay~~at ~~all~~September ~~reasonable~~30, ~~costs~~2017 and ~~fees~~December ~~attributable~~31, to2017 ~~the~~was ~~Patent~~$0.0156 ~~Rights~~per ~~including~~share ~~patent~~and ~~maintenance~~$0.01 ~~fees~~per share, ~~government fees and attorney fees~~respectively.

On5. ~~June~~LICENSE ~~17,~~AGREEMENT ~~2015,~~WITH ~~pursuant~~EMERGENT toHEALTH ~~a Swenson-Emergent Loan and Security Agreement, the Company consented to EMGE’s grant of a security interest in the License Agreement to a lender.~~ CORPORATION

9On ~~Table~~November 20, 2014, pursuant to the Stock Purchase Agreement involving a change in control of ~~Contents~~ENKS, ENKS was assigned effective January 1, 2015 the License Agreement between Cappello’s, Inc, (Licensor) and EMGE (Licensee) dated August 26, 2014 (the “EMGE License Agreement”) in exchange for the issuance of 2,000,000 restricted shares of ENKS common stock. The EMGE License Agreement was valued at its estimated fair value of $30,000 based upon 2014 royalties.

~~CASTLE~~The ~~HOLDING~~EMGE ~~CORP~~License Agreement provided for Licensee’s payment of quarterly royalty payments to Licensor equal to 5% of the first $1,000,000 of annual net sales of the Licensed Products, 4% of the next $1,000,000 of annual net sales, 3% of the next $1,000,000 of annual net sales, 2% of the next $2,000,000 of annual net sales, and 1% of all additional annual net sales. ~~AND~~The ~~SUBSIDIARIES~~term of the EMGE License Agreement was to upon the expiration of the last to expire of the Patent Rights. In the event the Base Sales of any one or more of the Licensed Products did not increase by 15% per year over each prior calendar year (“Underperforming Licensed Products”) and the Licensee did not pay royalties based on 15% annual increases in Base Sales for the Underperforming Licensed Product(s), Licensor could terminate the license for such Underperforming Licensed Product(s) or convert the license from an exclusive license to a non-exclusive license for such Underperforming Licensed Product(s). During the term, Licensor was to keep Licensee informed of the progress of the Patent Rights in the U.S. Patent Office and was to direct and control all aspects of the prosecution and maintenance of the Patent Rights using patent counsel of its choice; Licensee was to pay all reasonable costs and fees attributable to the Patent Rights including patent maintenance fees, government fees and attorney fees.

~~Notes~~9 toTable ~~Consolidated~~of ~~Financial Statements~~Contents

~~Three~~ENERKON ~~and~~SOLAR ~~Nine Months Ended June 30~~INTERNATIONAL, ~~2017~~INC. ~~and~~AND ~~2016~~SUBSIDIARIES

~~(Unaudited~~Notes ~~and~~to ~~Unreviewed)~~Consolidated Financial Statements

~~Based~~Three onMonths ~~the~~Ended calendar year 2015 sales of the licensed products reported to CHOD by EMGE, the Company was entitled to royalties of $18,528. However, the Company collected royalties of only $572 from EMGE in 2015. Due to the uncertainty of future collections from EMGE, the Company has not recognized the remaining $17,956 royalties due at December 31, ~~2015.~~2017 and 2016

~~EMGE~~(Unaudited ~~did not report sales of the Licensed Products to CHOD in the first quarter 2016 or the second quarter 2016~~ and did not remit any royalties to CHOD. On April 28, 2016, CHOD notified EMGE that the EMGE License Agreement was terminated. The Company plans to pursue the manufacturing and marketing of the Licensed Products through its subsidiary SAS Health and Beauty Corp.Unreviewed)

Based on the calendar year 2015 sales of the licensed products reported to ENKS by EMGE, the Company was entitled to royalties of $18,528. However, the Company collected royalties of only $572 from EMGE in 2015. Due to the uncertainty of future collections from EMGE, the Company has not recognized the remaining $17,956 royalties due at December 31, 2015.

InEMGE ~~November~~did not report sales of the Licensed Products to ENKS in the first quarter 2016, or the ~~Company~~second ~~collected~~quarter ~~$1,500~~2016 ofand ~~current~~did not remit any royalties ~~from~~to ENKS. On April 28, 2016, ENKS notified EMGE that the EMGE License Agreement was terminated.

6In November 2016, the Company collected $1,500 of current royalties from EMGE. ~~LOANS~~At ~~PAYABLE~~September TO30, ~~AFFILIATES~~2017, the Company recognized an impairment loss on the license agreement with Emergent Health Corporation of $30,000 and reduced the carrying value from $30,000 to $0.

~~Loan~~6. ~~payable~~LOANS toPAYABLE ~~affiliates~~TO ~~consist of:~~AFFILIATES

	June 30, 2017		September 30, 2016
SAS Health and Beauty Corp. Promissory
Note due John V. Cappello, chief executive
officer of the Company, non-interest
bearing, due December 1, 2016	$	15,000	$	15,000
Loans payable to entities affiliated with
president and former treasurer of the Company,
non-interest bearing, due on demand		3,081		3,081
Total	$	18,081	$	18,081

Loan payable to affiliates consist of:

7. STOCKHOLDERS’ EQUITY

	December 31, 2017		September 30, 2017

SAS Health and Beauty Corp. Promissory
Note due John V. Cappello, chief executive
officer of the Company, non-interest
bearing, due December 1, 2016	$	15,000	$	15,000

Loans payable to entities affiliated with
president and former treasurer of the Company,
non-interest bearing, due on demand		80		3,081

Total	$	15,080	$	18,081

~~Class~~7. ASTOCKHOLDERS’ ~~Convertible Preferred Stock~~EQUITY

~~From March 2001 to September 2001, CHC sold a total of 706,750 shares of~~ Class A Convertible Preferred Stock ~~for gross proceeds of $706,750.~~

~~Each~~From ~~share~~March of2001 ~~Class~~to ASeptember ~~Convertible~~2001, ~~Preferred~~ENKS ~~Stock~~sold isa ~~convertible~~total ~~at any time into one share~~ of ~~the Company’s Common Stock at the election of the Class A Convertible Preferred Stockholder. At any time~~706,750 ~~CHOD~~shares ~~may require conversion~~ of ~~the~~ Class A Convertible Preferred ~~Shares provided that CHOD Common~~ Stock ~~closes at a price of $1.50 per share or higher~~ for ~~more~~gross ~~than~~proceeds ~~20 consecutive business days. At any time after one year from the issue date~~ of ~~the Class A Convertible Preferred Shares, CHOD may require conversion of the Class A Convertible Preferred Shares provided that CHOD pay the Class A Convertible Preferred Stockholder~~ $0706,750.50 ~~per Class A Convertible Preferred Share.~~

~~The~~Each share of Class A Convertible Preferred ~~Shares~~Stock ~~are~~is ~~non-voting~~convertible ~~and~~at ~~have~~any atime ~~first~~into ~~priority~~one share of the Company’s Common Stock at the election of the Class A Convertible Preferred Stockholder. At any time, upENKS tomay require conversion of the Class A Convertible Preferred Shares provided that ENKS Common Stock closes at a price of $1.0050 per share or higher for more than 20 consecutive business days. At any time after one year from the issue date of the Class A Convertible Preferred ~~Share~~Shares, inENKS ~~the~~may ~~event~~require conversion of ~~liquidation~~the ofClass ~~CHOD~~A Convertible Preferred Shares provided that ENKS pay the Class A Convertible Preferred Stockholder $0.50 per Class A Convertible Preferred Share.

Table of Contents

~~CASTLE~~ENERKON ~~HOLDING~~SOLAR ~~CORP~~INTERNATIONAL, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

Three ~~and Nine~~ Months Ended ~~June~~December 3031, 2017 and 2016

(Unaudited and Unreviewed)

The Class BA Convertible Preferred ~~Stock~~Shares are non-voting and have a first priority, up to $1.00 per Class A Convertible Preferred Share, in the event of liquidation of ENKS.

~~Effective June 1, 2015, CHOD issued 100,000 shares of~~ Class B Preferred Stock (valued at $10,000) to John V. Cappello, chief executive officer of the Company, in connection with a $15,000 loan made to SAS Health and Beauty Corp., subsidiary of CHOD (see Note 6). Each share of Class B Preferred Stock is entitled to 100 votes per share but has no conversion, liquidation, or dividend rights.

~~Common~~Effective June 1, 2015, CHOD issued 100,000 shares of Class B Preferred Stock (valued at $10,000) to John V. Cappello, chief executive officer of the Company, in connection with a $15,000 loan made to SAS Health and Beauty Corp., subsidiary of ENKS (see Note 6). Each share of Class B Preferred Stock is entitled to 100 votes per share but has no conversion, liquidation, or dividend rights.

~~Effective~~Common April 1, 2016, CHOD issued a total of 2,000,000 restricted shares of CHOD common stock to a corporate investor in exchange for 1,500,000 free trading shares of Gold Mining USA Inc. ("GMUI") common stock. The transaction was valued at $0.035 per GMUI share or $52,500 total.Stock

On ~~May~~January 56, ~~2016~~2017, ~~CHOD~~the ~~issued~~bylaws ~~20,000~~of ~~restricted~~the ~~shares~~Company were amended by unanimous consent of ~~CHOD~~two ~~common~~stockholders ~~stock~~holding toa anmajority ~~attorney~~of ~~for~~the ~~legal~~voting ~~services~~rights of the Company’s stockholders. ~~The~~Among ~~transaction~~other ~~was~~things, ~~valued~~the atamended $0bylaws provide that the Company’s present chief executive officer John V.11 ~~per~~Cappello ~~CHOD~~be ~~share~~permitted 10 votes on any matter presented to the Board of Directors and that Cappello is to hold this voting right in perpetuity and may pass this voting right on or ~~$2,200~~relinquish ~~total~~it at his discretion in the future.

8. INCOME TAXES

~~CHOD~~ENKS files a consolidated income tax return with its subsidiaries for federal reporting purposes. ~~CHOD~~ENKS and its subsidiaries file separate income tax returns for state reporting purposes.

The provisions for (benefit from) income taxes consisted of:

	Nine Months Ended June 30,
	Three Months Ended December 31,
	2017			2016
Current:
Federal	$	-		$	-
State		-			-
Total		-			-
Deferred:
Federal		~~(13~~5,~~531~~893	)		(2113,~~512~~236	)
State		(21,~~767~~205	)		(42,~~399~~706	)
Change in valuation allowance		16(7,~~298~~098	)		2515,~~911~~942
Total		-			-
Provision for income taxes	$	-		$	-

Table of Contents

~~CASTLE~~ENERKON ~~HOLDING~~SOLAR ~~CORP~~INTERNATIONAL, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

Three ~~and Nine~~ Months Ended ~~June~~December 3031, 2017 and 2016

(Unaudited and Unreviewed)

The Company’s effective tax rate differed from the United States Federal income tax rate for the following reasons:

The Company’s effective tax rate differed from the United States Federal income tax rate for the following reasons:

	Three Months Ended December 31,
	2017			2016

Computed Federal income tax at 34%	$	6,303		$	(14,156	)
Computed state income tax, net of Federal tax effect		795			(1,786	)
Change in valuation allowance		(7,098	)		15,942

Provision for income taxes	$	-		$	-

	Nine Months Ended June 30,
	2017			2016
Computed Federal income tax at 34%	$	(21,272	)	$	(50,208	)
Computed state income tax, net of Federal tax effect		(2,684	)		(6,335	)
Non-deductible impairment of investment in Emergent Health Corporation common stock		7,658			30,632
Change in valuation allowance		16,298			25,911
Provision for income taxes	$	-		$	-

As a result of The Tax Cuts and Jobs Act (Tax Legislation) enacted on December 22, 2017, the United States corporation income tax rate is 21% effective January 1, 2018. Accordingly, we have reduced our deferred income tax asset relating to prior year net operating loss carryforwards and capital loss carryforwards (and the valuation allowance thereon) by $199,551 from $521,903 at September 30, 2017 to $322,352 at December 31, 2017.

Based on management's present assessment, the Company has not yet determined it to be more likely than not that a deferred tax asset of up to $~~405~~322,~~884~~352 attributable to the future utilization of $1,~~142~~132,~~747~~978 of prior year net operating loss carryforwards and $51402,~~030~~032 of capital loss carryforwards will be realized. Accordingly, the Company has maintained a 100% allowance against the deferred tax asset in the financial statements at ~~June~~September 30, 2017 and December 31, 2017. The Company will continue to review this valuation allowance and make adjustments as appropriate. The net operating loss carryforwards expire as follows: $~~180~~170,~~132~~363 in year 2021, $694,345 in year 2022, $135,943 in year 2023, $66,021 in year 2024, $39,208 in year 2025, and $27,098 in year 2036. The capital loss carryforward of $51402,~~030~~032 expires $49,175 in year 2018, ~~and~~ $1,855 in year 2021, and $351,002 in year 2022.

Current United States income tax laws limit the amount of loss available to be offset against future taxable income when a substantial change in ownership occurs. Therefore, the amount available to offset future taxable income may be limited.

9. COMMITMENTS AND CONTINGENCIES

Since December 2005, the Company has been using space in Freeport New York provided by a public accounting firm owned by the Company’s former treasurer at no cost to the Company.

From September 2015 to August 2016, the Company also occupied office space in King of Prussia, Pennsylvania under a lease at a rent of $950 per month. Since September 2016, the Company has been using other space in King of Prussia, Pennsylvania provided by EMGE at no cost to the Company. Management of the Company is currently working with EMGE to revive its business model and become viable.

12Effective ~~Table~~November 7, 2017, the chief executive officer and controlling shareholder of ~~Contents~~the Company completed an Escrow Agreement with certain parties affiliated with an entity engaged in solar energy operations. Under the agreement, a change in control of the Company would occur. Closing of the transaction is subject to completion of certain conditions precedent to closing.

Table of Contents

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

GENERAL

~~Castle~~Enerkon ~~Holding~~Solar ~~Corp~~International, Inc. (“~~CHOD~~ENKS”) is a holding company which was incorporated in Nevada on June 13, 1986. On September 30, 1987, ~~CHOD~~ENKS acquired Castle Securities Corp., a New York corporation which operated as a securities broker dealer from November 1, 1985 to October 31, 2003. On April 11, 1991, ~~CHOD~~ENKS formed Church Street Securities Corp., a New York corporation which operated as a securities broker dealer from October 26, 1995 to January 6, 2005. From January 2005 to June 2015, ~~CHOD~~ENKS and its subsidiaries had minimal business operations and operating revenues.

Commencing July 2015, ~~CHOD~~ENKS’s subsidiary SAS Health and Beauty Corp. (“SAS”) has engaged in the production and sales of a skin care product called “SAS Flower of Youth Facial Lift Spray.” In November 2016, SAS also started marketing two vitamin supplement products called “JDI MultiVitamin/MultiMineral with NeuStem” and “NeuStem”.

RESULTS OF OPERATIONS – Three Months ended ~~June~~December 3031, 2017 compared to Three Months ended ~~June~~December 3031, 2016.

Sales increased $1622,~~358~~156 from $~~959~~0 in 2016 to $1722,~~317~~156 in 2017. The increase in sales was due to the ~~introduction~~commencement of sales of our new vitamin supplement products in ~~late~~January 2017. In 2016, there were no sales of our skin care product as a result of our August 2016 disabling of our order processing software which was not working properly.

Cost of sales increased $43,~~426~~431 from $~~211~~0 in 2016 to $43,~~637~~431 in 2017.

Gross profit increased $1118,~~932~~725 from $~~748~~0 in 2016 to $1218,~~680~~725 in 2017 due to increased sales as a result of the introduction of ~~the~~our new vitamin supplement products discussed above. The gross profit percentage of sales in 2017 was approximately 7385%.

Total operating expenses increased $311,~~625~~959 from $165,~~078~~229 in 2016 to $1917,~~703~~188 in 2017. The increase was primarily due to fulfillment expenses and sales commissions incurred in 2017 relating to our vitamin supplement products.

Other income (expense) – net ~~decreased~~increased $7653,~~068~~405 from ($7636,~~171~~405) in 2016 to $~~103~~17,000 in 2017. The ~~decrease~~increase was due primarily to the $9056,~~485~~059 positive comparison in net gain (loss) on marketable securities from a loss of $9039,~~585~~059 in 2016 to a ~~loss~~gain of $~~100 in 2017~~17,000 ~~offset by a $14,501 decrease~~ in ~~interest and dividends revenues from $14,501 in 2016 to $0 in~~ 2017.

Net income (loss) ~~decreased~~increased $8460,~~375~~171 from ($9141,~~501~~634) in 2016 to $718,~~126~~537 in 2017. The ~~decrease~~increase was due to the $1118,~~932~~725 increase in gross profit and the $7653,~~068~~405 ~~decrease~~increase in other income (expense~~-net~~), offset partially by the $311,~~625~~959 increase in total operating expenses.

RESULTS OF OPERATIONS – Nine Months ended June 30, 2017 compared to Nine Months ended June 30, 2016.

Sales increased $28,550 from $8,212 in 2016 to $36,762 in 2017. The increase in sales was due to the introduction of our new vitamin supplement products in late 2016.

Cost of sales increased $6,458 from $1,058 in 2016 to $7,523 in 2017.

Gross profit increased $22,085 from $7,154 in 2016 to $29,239 in 2017 due to increased sales as a result of the introduction of the new products in late 2016. The gross profit percentage of sales in 2017 and 2016 was approximately 80% and 87%, respectively.

Table of Contents

Total operating expenses decreased $20,518 from $54,425 in 2016 to $33,907 in 2017. The decrease was primarily due to $20,000 of consulting fees incurred in 2016 relating to a Financial Public Relations Agreement executed in November 2015 which did not recur in 2017.

Other expense – net decreased $42,502 from $100,399 in 2016 to $57,897 in 2017. The decrease was due primarily to the $60,000 decrease in impairment expense of our investment in Emergent Health Corporation common stock, offset by the $19,970 decrease in interest and dividends revenues from $21,751 in 2016 to $1,601 in 2017.

Net loss decreased $85,105 from $147,670 in 2016 to $62,565 in 2017. The decrease was due to the $22,085 increase in gross profit, the $20,518 decrease in operating expenses, and the $42,502 decrease in other expense -net.

LIQUIDITY AND CAPITAL RESOURCES

At ~~June~~December 3031, 2017, the Company had cash and cash equivalents of $~~109~~115,~~900~~965, total assets of $~~195~~174,~~738~~950, total liabilities of $2118,~~508~~518, and total stockholders’ equity of $156,432. Of the $174,~~230~~950 total assets at December 31, 2017, $22,000 represents the quoted value of 1,000,000 shares of Gold Mining USA Inc. (GMUI) common stock and $20,000 represents the carrying value of 2,000,000 restricted shares of Emergent Health Corporation (EMGE) common stock.

Cash and cash equivalents ~~increased~~decreased $684,~~257~~675 from $41120,~~643~~640 at September 30, ~~2016~~2017 to $~~109~~115,~~900~~965 at ~~June~~December 3031, 2017. The $684,~~257~~675 ~~increase~~decrease was due primarily to the ~~sale of 32~~$7,~~000~~856 ~~shares~~increase ~~of Medallion Finance Group (MFIN) common stock~~ in ~~January 2017 for proceeds of $97,820~~inventory.

The Company currently has no ~~other~~ agreements, arrangements or understandings with any person to obtain funds through bank loans, lines of credit or any other sources.

We currently have no commitments with any person for any capital expenditures.

We have no off-balance sheet arrangements.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Since year ended September 30, 2002, Enerkon Solar International, Inc. (formerly Castle Holding Corp.) has had no principal accountant. Accordingly, there has been no disagreements with accountants on accounting and financial disclosure.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a “smaller reporting company” as defined by Rule 229.10(f)(1), we are not required to provide the information required by this Item 3.

ITEM 4. CONTROLS AND PROCEDURES

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, including our principal executive officer and ~~the~~ principal financial officer, we have conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded as of the evaluation date that our disclosure controls and procedures were effective such that the material information required to be included in our Securities and Exchange Commission reports is accumulated and communicated to our management, including our principal executive and financial officer, recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms relating to our company, particularly during the period when this report was being prepared.

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

There have been no changes in our internal control over financial reporting that occurred during the fiscal quarter ended ~~June~~December 3031, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

There are no pending legal proceedings to which the Company is a party or in which any director, officer or affiliate of the Company, any owner of record or beneficially of more than 5% of any class of voting securities of the Company, or security holder is a party adverse to the Company or has a material interest adverse to the Company. The Company’s property is not the subject of any pending legal proceedings.

ITEM 1A. RISK FACTORS

As a “smaller reporting company” as defined by Rule 229.10(f)(1), we are not required to provide the information required by this Item 1A.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

(a) Recent Sales of Unregistered Securities – In the three months ended ~~June~~December 3031, 2017, we did not sell any of our common stock or Class A Convertible Preferred Stock.

(b) Issuer Purchases of Equity Securities: In the three months ended ~~June~~December 3031, 2017, we did not purchase any of our common stock or Class A Convertible Preferred Stock.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

~~On July 17, 2017, Michael T~~None. ~~Studer resigned as chief financial officer and director of the Company.~~

Table of Contents

ITEM 6. EXHIBITS

The following exhibits are including with this filing:

3.1*	~~Articles of Incorporation (Form S-18 Registration No. 33-8395-LA, effective November 14, 1986)~~	Articles of Incorporation (Form S-18 Registration No. 33-8395-LA, effective November 14, 1986)
3.2*	~~Amendment to Articles of Incorporation (Form S-18 Registration No. 33-37809-NY, effective February 11, 1991)~~	Amendment to Articles of Incorporation (Form S-18 Registration No. 33-37809-NY, effective February 11, 1991)
3.2*	~~Amendment to Articles of Incorporation filed August 15, 2001 (September 30, 2001 Form 10-K filed January 15, 2002)~~	Amendment to Articles of Incorporation filed August 15, 2001 (September 30, 2001 Form 10-K filed January 15, 2002)
3.3*	~~By-laws (Form S-18 Registration No. 33-8395-LA, effective November 14, 1986)~~	By-laws (Form S-18 Registration No. 33-8395-LA, effective November 14, 1986)
4.4*	~~Specimen Stock Certificate (Form S-18 Registration No. 33-37809-NY, effective February 11, 1991)~~	Specimen Stock Certificate (Form S-18 Registration No. 33-37809-NY, effective February 11, 1991)
31.1	~~Sarbanes-Oxley Section 302 certification by John V. Cappello~~	Sarbanes-Oxley Section 302 certification by John V. Cappello
32.1	~~Sarbanes-Oxley Section 906 certification by John V. Cappello~~	Sarbanes-Oxley Section 906 certification by John V. Cappello
99.1*	~~Complaint for Injunctive and Other Relief (dated September 14, 1994) – Securities and Exchange Commission, Plaintiff (Form 8-K dated September 13, 1994)~~	Complaint for Injunctive and Other Relief (dated September 14, 1994) – Securities and Exchange Commission, Plaintiff (Form 8-K dated September 13, 1994)
99.3*	~~Distribution Agreement (Form 8-K filed October 29, 2014)~~	Distribution Agreement (Form 8-K filed October 29, 2014)
_________
* Previously filed and incorporated by reference.

____________

* Previously filed and incorporated by reference.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Castle Holding Corp.
	Enerkon Solar International, Inc.
Date: August 4, 2017	By:	/s/ John V. Cappello
Date: January 26, 2018	By:	/s/ John V. Cappello
		John V. Cappello
		Chief Executive Officer and Chief Financial Officer

Filing Compare · ENERKON SOLAR INTERNATIONAL, INC.